AXOGEN INC. - COMMON STOCK
13.34
22-11月-24 15:44:58
15 分の遅延
株式
+0.24
+1.83%
本日の幅
12.99 - 13.40
ISIN
N/A
ソース
NASDAQ
-
Axogen, Inc. Appoints Marc Began as Executive Vice President and General Counsel
06 3 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
02 3 2023 15:00:00 提供 Nasdaq GlobeNewswire
-
Axogen, Inc. Appoints Jens Schroeder Kemp as Chief Marketing Officer
13 2 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022
09 1 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
05 1 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
Axogen to Participate at J.P. Morgan 41st Annual Healthcare Conference
04 1 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
19 12 2022 06:00:00 提供 Nasdaq GlobeNewswire
-
Axogen, Inc Reports 2022 Third Quarter Financial Results
08 11 2022 06:00:02 提供 Nasdaq GlobeNewswire
-
Axogen to Participate at Upcoming Investor Conferences
03 11 2022 15:00:00 提供 Nasdaq GlobeNewswire
-
31 10 2022 06:00:00 提供 Nasdaq GlobeNewswire
-
20 10 2022 06:00:01 提供 Nasdaq GlobeNewswire
-
Axogen to Participate in the 77th Annual Meeting of the American Society for Surgery of the Hand
22 9 2022 06:00:00 提供 Nasdaq GlobeNewswire
-
Axogen, Inc Reports 2022 Second Quarter Financial Results
03 8 2022 15:01:01 提供 Nasdaq GlobeNewswire
-
Axogen, Inc. to present at Canaccord Genuity's 42nd Annual Growth Conference
29 7 2022 06:00:00 提供 Nasdaq GlobeNewswire
-
18 7 2022 15:00:00 提供 Nasdaq GlobeNewswire
-
Axogen, Inc. Appoints William Burke to Board of Directors
11 7 2022 06:00:00 提供 Nasdaq GlobeNewswire
-
18 5 2022 06:00:00 提供 Nasdaq GlobeNewswire
-
Axogen, Inc Reports 2022 First Quarter Financial Results
04 5 2022 15:05:01 提供 Nasdaq GlobeNewswire
-
Axogen, Inc. Announces Positive Topline Results from Phase 3 RECON(SM) Study for Avance® Nerve Graft
04 5 2022 15:01:00 提供 Nasdaq GlobeNewswire
-
Axogen, Inc. to Report First Quarter 2022 Financial Results and Host Conference Call on May 4, 2022
13 4 2022 06:00:00 提供 Nasdaq GlobeNewswire